Web Analytics




Home Tags Posts tagged with "LaNova Medicines"

Tag: LaNova Medicines

Sino Biopharmaceutical's LaNova acquisition
Deal Highlights

Han Kun, Zhong Lun act on Sino Biopharm’s USD950m LaNova buy

Han Kun and Zhong Lun advised on Sino Biopharm’s USD950m acquisition of cancer drugmaker LaNova Medicines

0

LATEST ON LAW.ASIA

MOST READ ON LAW.ASIA

Bangladesh A-list Feat

A-List: Bangladesh 2026

Following an extensive nomination process, Asia Business Law Journal reveals the top lawyers in Bangladesh

IREDA sustainable loan financing

Baker McKenzie, JSA, Luthra act on IREDA’s JPY28bn green loan

Financial disputes in ADR mechanisms

Addressing financial disputes in ADR mechanisms

By Chen Yanhong, DHH Law Firm
Peter McDonald A&O Shearman Australia

A&O Shearman unveils new co-managing partner for Australia

KKR SK Renewable Energy Platform

KKR, SK launch Korea’s largest renewable energy platform

India GCC compliance frameworkvideo

Setting up a GCC in India

By Vikas Agarwal and Vivek Sadhale, LegaLogic Consulting

Correspondents

SEC and the cost of local capital market investment

SEC and the cost of local capital market investment

By Luke Morgan B Codilla, ACCRALAW
Arbitration Clause Drafting

Consent, clarity and arbitration clause lessons

By Hiral Gupta and Surabhi Sharan, Bharucha & Partners
India Green Channel Route

Green Channel Route: Gains and predictability

By Vandana Pai and Hardik Dave, Bharucha & Partners
Impact Investing Compliancevideo

Impact investing: Do use of proceeds clauses actually work?

By Mita Sood, Bharucha & Partners
Follow Law.asia
Law firms Awards Events Legal jobs • Post a job
About us Archive Subscribe Contact us
Please send any press releases, deal announcements, details of new hires, newsletters and any other news items to: news@law.asia
© Copyright 2026 Law.asia Limited. All rights reserved.

Follow us on LinkedIn

Follow now